These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2819453)

  • 1. Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro.
    Tsagarakis S; Rees LH; Besser GM; Grossman A
    Brain Res; 1989 Nov; 502(1):167-70. PubMed ID: 2819453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
    Korbonits M; Little JA; Forsling ML; Tringali G; Costa A; Navarra P; Trainer PJ; Grossman AB
    J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
    Tsagarakis S; Holly JM; Rees LH; Besser GM; Grossman A
    Endocrinology; 1988 Oct; 123(4):1962-9. PubMed ID: 2970959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPY Y1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro.
    Hastings JA; McClure-Sharp JM; Morris MJ
    Brain Res; 2001 Jan; 890(1):32-7. PubMed ID: 11164766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
    Tsagarakis S; Navarra P; Rees LH; Besser M; Grossman A; Navara P
    Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism.
    Cambronero JC; Rivas FJ; Borrell J; Guaza C
    Eur J Pharmacol; 1992 Aug; 219(1):75-80. PubMed ID: 1327836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats.
    Russell SH; Small CJ; Dakin CL; Abbott CR; Morgan DG; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2001 Jun; 13(6):561-6. PubMed ID: 11412343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Suda T; Tozawa F; Iwai I; Sato Y; Sumitomo T; Nakano Y; Yamada M; Demura H
    Brain Res Mol Brain Res; 1993 Jun; 18(4):311-5. PubMed ID: 8392133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission.
    Haas DA; George SR
    Brain Res; 1989 Oct; 498(2):333-8. PubMed ID: 2551461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts.
    Robidoux J; Simoneau L; St-Pierre S; Masse A; Lafond J
    Endocrinology; 2000 Aug; 141(8):2795-804. PubMed ID: 10919265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus.
    Tsagarakis S; Gillies G; Rees LH; Besser M; Grossman A
    Neuroendocrinology; 1989 Jan; 49(1):98-101. PubMed ID: 2785660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y.
    Heinrichs SC; Menzaghi F; Pich EM; Hauger RL; Koob GF
    Brain Res; 1993 May; 611(1):18-24. PubMed ID: 8518948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions.
    Haas DA; George SR
    Life Sci; 1987 Dec; 41(25):2725-31. PubMed ID: 2826949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms.
    Parker SL; Crowley WR
    Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase.
    Pozzoli G; Tringali G; Dello Russo C; Vairano M; Preziosi P; Navarra P
    J Neuroimmunol; 2001 Aug; 118(2):268-76. PubMed ID: 11498261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.
    Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Life Sci; 1987 Feb; 40(7):673-7. PubMed ID: 3492648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of serotonin and norepinephrine on CRF release from hypothalami in vitro.
    Tate PW; Newell DC; Cook EE; Martinson DR; Hagen TC
    Horm Metab Res; 1983 Jul; 15(7):342-6. PubMed ID: 6309639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural Characterization of Corticotropin-Releasing Factor and Neuropeptide Y in the Rat Locus Coeruleus: Anatomical Evidence for Putative Interactions.
    Theisen CC; Reyes BAS; Sabban EL; Van Bockstaele EJ
    Neuroscience; 2018 Aug; 384():21-40. PubMed ID: 29775703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.
    Gué M; Yoneda M; Mönnikes H; Junien JL; Taché Y
    Br J Pharmacol; 1992 Nov; 107(3):642-7. PubMed ID: 1472962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP; Clarke IJ; Funder JW; Engler D
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.